Insider Transactions in Q4 2024 at Intellia Therapeutics, Inc. (NTLA)

NTLA Quotes by TradingView

Insider Transaction List (Q4 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Oct 02 2024
Michael P Dube VP, Chief Accounting Officer
SELL
Open market or private sale
Direct
2,012 -4.1%
$38,228 $19.01 P/Share

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA